Update on HIV/AIDS in Thailand.

Area of Science:

• Epidemiology
• Virology
• Immunology

Background:

• Thailand's first AIDS case was in 1984, with significant HIV-1 epidemic waves impacting various populations.
• Subtype A/E is predominant (96%) in Thai HIV-1 infections, with subtype B' being less common.

Purpose of the Study:

• To analyze the epidemiological trends, clinical characteristics, and treatment challenges of the HIV/AIDS epidemic in Thailand.
• To evaluate factors influencing disease progression, survival rates, and potential long-term non-progression in the Thai population.

Main Methods:

• Analysis of HIV epidemic waves, viral subtypes, CD4 counts, survival data, and genetic polymorphisms (SDF1-3'A).
• Review of clinical manifestations, opportunistic infections, and current antiretroviral therapy (ART) guidelines and challenges in Thailand.

Main Results:

• Median time to CD4 <200 cells/microL was 6.8 years in male seroconverters; 5-year survival was 82% for subtype A/E vs. 90% for subtype B.
• Homozygous SDF1-3'A polymorphism found in 13.5% of seronegatives suggests potential long-term non-progression.
• Primary HIV infection syndrome is rare (1.1%) in Thais, unlike Western cohorts (50-90%).

Conclusions:

• Despite declining seroprevalence due to multidisciplinary efforts, challenges remain in ART affordability and access in Thailand.
• Further grassroots-level efforts are crucial for sustained control of the HIV epidemic.
• Ongoing vaccine trials and research into ART optimization are vital for improving patient outcomes.